Pharmacological treatment of Tourette's syndrome: from the past to the future

Neurol Sci. 2024 Mar;45(3):941-962. doi: 10.1007/s10072-023-07172-2. Epub 2023 Nov 14.

Abstract

Tourette's syndrome (TS) is a neuropsychiatric disease featuring tics and vocal tics, with a prevalence of approximately 1%, including 75% of the total number of male patients. TS seriously disturbs the patients' career, education, and life and brings a serious and unbearable psychological burden to the patients themselves and their families. At present, there are no specific clinical medications recommended for treating TS. Therefore, it is necessary to select the appropriate medication for symptomatic treatment based on the doctor's personal experience and the patient's symptoms, with the main goal of relieving symptoms, thus improving the patient's social skills and psychological problems. Here we conducted a comprehensive search on PubMed to review and organize the history and current status of the development of drug therapy for TS through a timeline format. We also systematically evaluated the effects of each drug for TS treatment to summarize the current problems and new research directions and to provide some ideas for clinical treatment.

Keywords: Tourette’s syndrome; drug evidence assessment; pharmacology treatment.

Publication types

  • Review

MeSH terms

  • Humans
  • Male
  • Tic Disorders*
  • Tics* / drug therapy
  • Tourette Syndrome* / diagnosis
  • Tourette Syndrome* / drug therapy